• Home
  • Our Services
  • Patients
  • Volunteer
  • Sponsors and CROs
  • Our Staff
  • Equipment
  • More
    • Home
    • Our Services
    • Patients
    • Volunteer
    • Sponsors and CROs
    • Our Staff
    • Equipment
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Our Services
  • Patients
  • Volunteer
  • Sponsors and CROs
  • Our Staff
  • Equipment

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

What is a clinical trial?

A clinical trial is a research study designed to evaluate a medical intervention's safety, efficacy, and/or effectiveness, such as a new drug, therapy, medical device, or treatment procedure. These trials are conducted with human participants, often patients, to assess the potential benefits and risks of the intervention.


Clinical trials are typically conducted in multiple phases: Phase I, Phase II, Phase III, and Phase IV.


Clinical trials follow strict protocols and are conducted under the supervision of trained medical professionals and researchers. Participants in clinical trials are required to provide informed consent after receiving detailed information about the study's objectives, procedures, potential risks, and benefits.

Phase I

Phase III

Phase II

These trials are the first step in testing a new intervention in humans. They primarily focus on assessing the intervention's safety and dosage levels. 


Length of Study: Several months


Approximately 70% of drugs move to the next phase.

Phase II

Phase III

Phase II

Phase two tests the treatment on a larger group of patients to evaluate safety, dosage, and efficacy.


Length of Study: Several months to 2 years


Approximately 33% of drugs move to the next phase.


Phase III

Phase III

Phase III

Phase III trials confirm treatment effectiveness, compare with standard treatments, and evaluate safety and side effects among a larger patient population.


Length of Study: 1 to 4 years


Approximately 25-30% of drugs move to the next phase

Phase IV

Phase III

Phase III

Phase IV trials are conducted after regulatory approval to monitor the intervention's long-term safety and effectiveness in real-world settings, identifying rare or long-term side effects.




SOURCE FDA.GOV

Who can participate in a clinical trial?

Clinical trials allow people from different backgrounds and with various health conditions to participate in medical research. Anyone can participate, regardless of age, health, ethnicity, or social background. There's usually no need for insurance, proof of legal status, or citizenship. These trials may involve healthy volunteers or individuals with specific illnesses or medical conditions.

Who can participate according to NIH

Participating in clinical trials can offer several potential

Access to New Treatments

Clinical trials offer advanced investigational therapies that can help those who have exhausted standard treatments or seek alternatives.

Contribution to Medical Knowledge

Participating in clinical trials advances medical science, improves patient care, and helps develop new treatments for diseases while enhancing existing therapies.

Close Monitoring and Care

Clinical trial participants receive ongoing monitoring and medical attention from experienced professionals to detect and treat health issues early, promoting well-being.

Potential for Improved Health Outcomes

Clinical trial participation may lead to improved health outcomes, including better symptom management, disease control, or remission due to investigational treatments.

Financial Assistance

Clinical trial participants may receive compensation for their time, travel expenses, and other costs.

Empowerment and Support

Clinical trials offer a chance for empowerment and emotional support by connecting individuals facing similar health challenges.

Contribution to Public Health

Clinical trials benefit public health by developing safe and effective treatments.

NIH -National Institute of Aging

What is patient consent?

Patient consent is fundamental in clinical research. At MQRA, we prioritize the highest ethical standards and informed consent in our trials. Our team ensures a transparent consent process, providing clear information to participants. We adhere to guidelines and ethical principles to safeguard participants and build trust through communication and support. Our goal is to advance medical science with integrity and compassion.

Privacy Assurance/HIPPA

We prioritize the privacy of participant information in our clinical trial operations at MQRA. We comply with HIPAA regulations and maintain strict confidentiality standards by implementing robust policies, procedures, and technologies. Our measures include access controls, encryption protocols, regular audits, and ongoing staff training. By doing so, we uphold participant trust, preserve research integrity, and prioritize data privacy.

MQRA Patients Share Their Success Stories!

GET IN TOUCH

2908 West Waters Avenue, Suite 101A Tampa, Florida 33614

(813)-935-1944 info@mqualityresearch.com

Hours

Open today

09:00 am – 05:00 pm

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Copyright © 2023, Medical Quality Research Alliance Inc. All Rights Reserved.

Powered by

  • Home
  • Our Services
  • Our Staff
  • Equipment

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept

Announcement

 Want to participate in one of our clinical trials?

Learn more